Finance

Lists
Why is MDNA down 2.25%?
Dive Deeper
MDNA:TSE
Medicenna Therapeutics Corp
CA$0.44
-2.25%
(-0.0100) 1D
Oct 9, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MDNA...
Open
CA$0.44
High
CA$0.44
Low
CA$0.43
Mkt. cap
40.15M
Avg. vol.
43.95K
Volume
3.00K
52-wk high
CA$1.97
52-wk low
CA$0.34
EPS
-CA$0.22
Beta
1.77
Shares outstanding
92.30M
No. of employees
15
Open
CA$0.44
High
CA$0.44
Low
CA$0.43
Mkt. cap
40.15M
Avg. vol.
43.95K
Volume
3.00K
52-wk high
CA$1.97
52-wk low
CA$0.34
EPS
-CA$0.22
Beta
1.77
Shares outstanding
92.30M
No. of employees
15
News stories
From web sources and news partners
About Medicenna Therapeutics Corp
CEO-
Employees15
Founded2015
HeadquartersToronto, Ontario, Canada
SectorBiotechnology
Websitemedicenna.com
Last report
Nov 4, 2022
Fiscal period
Q2 2023
-CA$0.07 / -CA$0.07
-7.84%miss
Revenue / Est. (CAD)
- / 0.00
Fiscal Q2 2023 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.11M
4.07M
4.50M
4.24M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.36M
1.54M
1.32M
1.21M
Operating expense
5.47M
5.62M
5.82M
5.45M
Total operating expenses
5.47M
5.62M
5.82M
5.45M
Operating income
-5.47M
-5.62M
-5.82M
-5.45M
Other non operating income
200.00K
1.29M
1.51M
400.00K
EBT including unusual items
-4.88M
-4.36M
-4.23M
-5.08M
EBT excluding unusual items
-4.88M
-4.36M
-4.23M
-5.08M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.88M
-4.36M
-4.23M
-5.08M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
158.00K
114.00K
53.00K
25.00K
Interest expense
-
-
-
-
Net interest expenses
158.00K
114.00K
53.00K
25.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.46M
-5.61M
-5.82M
-5.45M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps